junidude14 commited on
Commit
592efd9
·
verified ·
1 Parent(s): ee88762

Archive 4 checkpoints (1-4)

Browse files
paper-releases/pbisc-diffusion/updates/20261004T165054Z-rare-states-screen/diffusion/dataset/server_1/model8/plans/rare_states_screen_20261004/README.md ADDED
@@ -0,0 +1,86 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ # Rare disease-associated states beyond C1Q-high monocytes (2026-10-04/05)
2
+
3
+ **Question (user).** The model seems to follow the rise of C1Q-high monocytes to some degree. Which other rare,
4
+ disease-specific subtypes would be worth testing the same way?
5
+
6
+ **Two parts.**
7
+ 1. A literature survey of rare PBMC states.
8
+ - 14 candidates, with key papers and marker genes.
9
+ - 43 PDFs in `paper-release-20260928/reference-papers/rare-disease-states/`, listed in the `INDEX.md` there.
10
+ 2. A screen of the zero-shot arms we already had, with no new generation:
11
+ - The arms are DRESS (in the corpus), and Kawasaki and SLE GSE135779 (not in the corpus).
12
+ - Model: final f01 6k E16. Each sample's own pseudobulk is the condition at K = 1,000, with seed 20260913.
13
+ - Read-out: Poisson, seed 20260916. Labels: frozen f01common scANVI.
14
+ - Each state was scored on generated and observed cells with the paper-based marker rules in
15
+ `tools/states.json`.
16
+ - Observed parent cells are binomially thinned to the generated median library, as in `c1q_crossdisease`.
17
+
18
+ ## Results (counts: state cells / parent cells; observed thinned)
19
+
20
+ | state (rule) | dataset | generated | observed | gen/obs | Spearman | disease direction |
21
+ |---|---|---|---|---:|---:|---|
22
+ | **MS1 monocyte** (IL1R2 + ≥ 2 of RETN ALOX5AP CYP1B1 MCEMP1 PLAC8 CLU CD163) | Kawasaki | KD before 317 / 4,450; HC 0 / 798; after IVIG 28 / 2,679 | 697 / 5,923; 1 / 1,123; 16 / 4,004 | 0.67 | 0.55 | **both kept** |
23
+ | | SLE | 21 / 21,833 | 3,105 / 70,901 | 0.02 | −0.03 | lost |
24
+ | **ISG-high T** (≥ 4 of 10 ISGs) | SLE | aSLE 746 / 12,979; aHD 29 / 10,265; cSLE 4,989 / 60,156; cHD 55 / 23,121 | 3,767 / 20,730; 175 / 27,704; 21,953 / 111,977; 450 / 56,080 | 0.45 | **0.86** | **both kept** |
25
+ | ISG-high monocyte (positive control) | SLE | 7,372 / 21,833 | 27,715 / 70,901 | 0.86 | 0.86 | both kept |
26
+ | **Cycling T/NK** (≥ 2 of MKI67 TOP2A TYMS CENPF UBE2C BIRC5) | SLE | 688 / 124,845 | 1,553 / 238,992 | 0.85 | 0.68 | both kept |
27
+ | | DRESS | patient 32 / 3,857; HV 1 / 3,370 | 882 / 5,633; 20 / 5,650 | 0.32 | 0.78 | kept, compressed |
28
+ | | Kawasaki | 92 / 45,425 | 1,163 / 63,360 | 0.11 | 0.34 | mixed |
29
+ | **Plasmablast** (scANVI 'Plasma cell') | Kawasaki | 206 / 75,000 | 1,837 / 103,362 | 0.16 | 0.56 | kept (KD vs HC, before vs after) |
30
+ | | SLE | 85 / 168,000 | 1,526 / 358,235 | 0.12 | 0.19 | child kept, adult reversed |
31
+ | C1Q-high monocyte (reference) | Kawasaki / SLE / DRESS | 43 / 7,927; 109 / 21,833; 110 / 3,793 | 603 / 11,050; 1,800 / 70,901; 529 / 4,485 | 0.10 / 0.20 / 0.25 | 0.17 / 0.43 / 0.96 | mixed |
32
+ | **DN2 / ABC B** (ITGAX or TBX21 + ≥ 2 of 7, CR2 absent) | SLE | 40 / 19,311 | 931 / 35,488 | 0.08 | 0.04 | adult weak, child reversed |
33
+ | HSPC (≥ 2 of CD34 PRSS57 SPINK2 SMIM24) | SLE | 12 / 168,000 | 265 / 358,235 | 0.10 | 0.13 | too rare to judge |
34
+ | **Granulocyte-like / LDG** (≥ 2 of 9 granule and neutrophil genes) | Kawasaki | 16 / 75,000 | 2,974 / 103,362 | **0.007** | 0.85 | not generated |
35
+
36
+ The full tables are in `out/summary.csv`, `out/contrasts.csv` and `out/per_sample.csv`. The v1 run used provisional
37
+ marker rules; its tables are kept in `out/v1_provisional_markers/`.
38
+
39
+ **Corpus frequency** (`out/corpus_states.csv`; corpus sample of 179,750 cells, native depth):
40
+ - MS1 (IL1R2+) is 6.9 % of monocytes, mostly from the COVID datasets.
41
+ - ISG-high T is 5.2 % of T cells.
42
+ - DN2 / ABC is 5.2 % of B cells.
43
+ - Granulocyte-like cells are 2.4 % of all cells.
44
+ - Plasmablasts (label) are 0.47 % of all cells.
45
+
46
+ So the poorly generated states, DN2 and LDG, are **present in the corpus**. Corpus absence does not explain them.
47
+
48
+ ## Reading
49
+
50
+ 1. **What is reproduced, even outside the corpus.** These are states carried by a strong, broad program in the bulk:
51
+ - Kawasaki MS1 monocytes: present before IVIG, absent in controls, gone after IVIG.
52
+ - SLE ISG-high T cells, a rare state in healthy donors.
53
+ - Cycling T cells in SLE.
54
+
55
+ Direction and sample ranking are kept. Kawasaki MS1 matches the Gold 2026 reanalysis of the same cohort.
56
+ 2. **What is compressed but directional.** Plasmablasts and C1Q-high monocytes come out at 0.1–0.25× and follow the
57
+ disease direction only in some contrasts.
58
+ 3. **What fails.**
59
+ - DN2 / ABC B cells: 0.08×, no sample tracking.
60
+ - Granulocyte-like / LDG cells: essentially never generated, although present in the corpus.
61
+ - HSPC: too rare to judge at these cell numbers.
62
+ 4. **Caveats.**
63
+ - Zero-shot and pseudobulk-conditioned, one seed, marker-rule states.
64
+ - The DRESS samples were training samples.
65
+ - The Kawasaki data are 10x 5′.
66
+ - SLE MS1 in observed cSLE (6.5 %) may partly reflect granulocyte contamination; it is not reproduced.
67
+
68
+ ## Next test (not run; needs user approval)
69
+
70
+ Ye 2026 sepsis is the paired cohort (80 donors, real bulk) where the 5-fold LoRA-5 arms already exist:
71
+ - labels are local in `paired_finetune_intradataset_20260927/scores/ye2026_sepsis/fold*/arms/`;
72
+ - the NPZs are on spark-0110.
73
+
74
+ Scoring MS1, the Ye proliferating CD14 monocytes, plasmablasts and C1Q on held-out donors there is **CPU only**. It
75
+ needs the NPZs copied back, a Poisson read-out on the marker genes and this screen. It would test the strongest
76
+ candidates with real bulk and LoRA.
77
+
78
+ ## Files
79
+
80
+ - `tools/screen.py`: generated vs observed per state.
81
+ - `tools/corpus_states.py`: corpus frequency, using the same rules.
82
+ - `tools/states.json`: the state rules.
83
+ - Runs were bounded `systemd-run --user` CPU units (MemoryMax 28G, no swap); logs are in `work/`.
84
+ - The generated read-out h5ads were copied back from spark-0110 to a scratch directory for the run, sha-checked
85
+ against their `.moved` markers, and deleted afterwards. So were the corpus sample h5ad and the `behcet_c1q_lora3`
86
+ corpus sample. The originals remain on spark-0110.
paper-releases/pbisc-diffusion/updates/20261004T165054Z-rare-states-screen/diffusion/dataset/server_1/model8/plans/rare_states_screen_20261004/out/contrasts.csv ADDED
@@ -0,0 +1,76 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ dataset,state,contrast,obs_a,obs_b,gen_a,gen_b,obs_a_counts,obs_b_counts,gen_a_counts,gen_b_counts,obs_diff,gen_diff,same_direction
2
+ dress,C1Q-high monocyte (reference),DRESS|none - healthy|none,3.8184438040345823,1.641867624422781,2.127659574468085,0.9581881533101045,53 / 1388,32 / 1949,15 / 705,11 / 1148,2.1765761796118013,1.1694714211579806,True
3
+ dress,Cycling T/NK,DRESS|none - healthy|none,15.657731226699804,0.35398230088495575,0.8296603577910293,0.02967359050445104,882 / 5633,20 / 5650,32 / 3857,1 / 3370,15.303748925814848,0.7999867672865782,True
4
+ dress,Cycling activated T (CD38/HLA-DR),DRESS|none - healthy|none,23.24805339265851,1.1798799420409853,0.8387445887445888,0.06956521739130435,1254 / 5394,57 / 4831,31 / 3696,2 / 2875,22.068173450617522,0.7691793713532844,True
5
+ dress,Proliferating T (label),DRESS|none - healthy|none,43.770856507230256,1.2212792382529496,1.893939393939394,0.17391304347826086,2361 / 5394,59 / 4831,70 / 3696,5 / 2875,42.54957726897731,1.7200263504611333,True
6
+ dress,Plasmablast (label),DRESS|none - healthy|none,0.5663856691253951,0.02328830926874709,0.24,0.04,43 / 7592,2 / 8588,12 / 5000,2 / 5000,0.543097359856648,0.19999999999999998,True
7
+ dress,Plasmablast (markers),DRESS|none - healthy|none,1.3435194942044257,0.8383791336748952,0.42,0.14,102 / 7592,72 / 8588,21 / 5000,7 / 5000,0.5051403605295305,0.27999999999999997,True
8
+ dress,MS1 monocyte (IL1R2+),DRESS|none - healthy|none,2.5936599423631126,0.2565418163160595,2.4113475177304964,0.17421602787456447,36 / 1388,5 / 1949,17 / 705,2 / 1148,2.337118126047053,2.237131489855932,True
9
+ dress,Cycling monocyte (Ye 2026),DRESS|none - healthy|none,5.9077809798270895,0.513083632632119,0.14184397163120568,0.08710801393728224,82 / 1388,10 / 1949,1 / 705,1 / 1148,5.39469734719497,0.05473595769392345,True
10
+ dress,ISG-high monocyte (positive control),DRESS|none - healthy|none,2.9538904899135447,4.104669061056952,2.5531914893617023,0.7839721254355401,41 / 1388,80 / 1949,18 / 705,9 / 1148,-1.150778571143407,1.7692193639261622,False
11
+ dress,ISG-high T,DRESS|none - healthy|none,1.8909899888765296,0.49679155454357277,0.13528138528138528,0.034782608695652174,102 / 5394,24 / 4831,5 / 3696,1 / 2875,1.3941984343329568,0.10049877658573311,True
12
+ dress,DN2 / ABC B,DRESS|none - healthy|none,1.3333333333333333,4.223227752639517,2.147239263803681,0.6116207951070336,5 / 375,28 / 663,7 / 326,2 / 327,-2.8898944193061844,1.5356184686966474,False
13
+ dress,HSPC,DRESS|none - healthy|none,0.1053740779768177,0.13972985561248252,0.08,0.02,8 / 7592,12 / 8588,4 / 5000,1 / 5000,-0.034355777635664816,0.06,False
14
+ dress,Cytotoxic CD4 T,DRESS|none - healthy|none,0.23719165085388993,0.34947578632051923,0.6863140896245459,1.3230429988974641,5 / 2108,7 / 2003,17 / 2477,12 / 907,-0.1122841354666293,-0.6367289092729183,True
15
+ dress,Granulocyte-like (LDG),DRESS|none - healthy|none,3.4378292939936776,2.841173730787145,0.0,0.0,261 / 7592,244 / 8588,0 / 5000,0 / 5000,0.5966555632065327,0.0,False
16
+ dress,Platelet signal in monocytes (negative control),DRESS|none - healthy|none,2.0172910662824206,1.128783991790662,0.5673758865248227,0.5226480836236934,28 / 1388,22 / 1949,4 / 705,6 / 1148,0.8885070744917587,0.04472780290112932,True
17
+ kawasaki,C1Q-high monocyte (reference),KD_before - HC,7.034004119249997,4.110992674337189,0.47869559232578546,0.12919896640826875,344 / 5923,45 / 1123,21 / 4450,1 / 798,2.9230114449128077,0.34949662591751673,True
18
+ kawasaki,C1Q-high monocyte (reference),KD_before - KD_after,7.034004119249997,3.986112457411569,0.47869559232578546,0.8372597070796717,344 / 5923,214 / 4004,21 / 4450,21 / 2679,3.047891661838428,-0.3585641147538862,False
19
+ kawasaki,Cycling T/NK,KD_before - HC,1.1625467330728516,0.9341547107176998,0.2626607954014015,0.03930267517601507,194 / 18293,105 / 11535,37 / 14265,4 / 9829,0.22839202235515177,0.22335812022538645,True
20
+ kawasaki,Cycling T/NK,KD_before - KD_after,1.1625467330728516,2.583978601078479,0.2626607954014015,0.24308549451659656,194 / 18293,864 / 33532,37 / 14265,51 / 21331,-1.4214318680056275,0.01957530088480497,False
21
+ kawasaki,Cycling activated T (CD38/HLA-DR),KD_before - HC,1.120651919571107,1.4190112632069425,0.2553029211738954,0.04309543105579807,169 / 16366,142 / 10135,33 / 13373,4 / 9110,-0.2983593436358354,0.21220749011809734,False
22
+ kawasaki,Cycling activated T (CD38/HLA-DR),KD_before - KD_after,1.120651919571107,5.07135725383796,0.2553029211738954,0.2901674587377889,169 / 16366,1569 / 30531,33 / 13373,57 / 19925,-3.9507053342668534,-0.03486453756389346,True
23
+ kawasaki,Proliferating T (label),KD_before - HC,1.059921430997219,1.649853224950404,0.9147467222381316,0.5476650248410975,158 / 16366,164 / 10135,125 / 13373,50 / 9110,-0.5899317939531852,0.3670816973970341,False
24
+ kawasaki,Proliferating T (label),KD_before - KD_after,1.059921430997219,2.85960133022599,0.9147467222381316,0.7812466630738043,158 / 16366,824 / 30531,125 / 13373,155 / 19925,-1.7996798992287713,0.13350005916432728,False
25
+ kawasaki,Plasmablast (label),KD_before - HC,1.437192652609059,0.7046814844440664,0.2533333333333333,0.16,498 / 36717,116 / 16203,76 / 30000,24 / 15000,0.7325111681649926,0.0933333333333333,True
26
+ kawasaki,Plasmablast (label),KD_before - KD_after,1.437192652609059,2.439870061643063,0.2533333333333333,0.35333333333333333,498 / 36717,1223 / 50442,76 / 30000,106 / 30000,-1.002677409034004,-0.10000000000000003,True
27
+ kawasaki,Plasmablast (markers),KD_before - HC,3.158656607178958,2.4582929968449747,0.6166666666666667,0.37333333333333335,1178 / 36717,400 / 16203,185 / 30000,56 / 15000,0.7003636103339832,0.24333333333333335,True
28
+ kawasaki,Plasmablast (markers),KD_before - KD_after,3.158656607178958,10.505593092593829,0.6166666666666667,0.54,1178 / 36717,5202 / 50442,185 / 30000,162 / 30000,-7.34693648541487,0.07666666666666666,False
29
+ kawasaki,MS1 monocyte (IL1R2+),KD_before - HC,8.527892659909776,0.1388888888888889,4.280527498898508,0.0,697 / 5923,1 / 1123,317 / 4450,0 / 798,8.389003771020887,4.280527498898508,True
30
+ kawasaki,MS1 monocyte (IL1R2+),KD_before - KD_after,8.527892659909776,0.37914278854109856,4.280527498898508,0.8833807597463187,697 / 5923,16 / 4004,317 / 4450,28 / 2679,8.148749871368677,3.397146739152189,True
31
+ kawasaki,Cycling monocyte (Ye 2026),KD_before - HC,2.6128784313341473,1.9098887739355497,0.2512150570122724,0.0,167 / 5923,20 / 1123,14 / 4450,0 / 798,0.7029896573985976,0.2512150570122724,True
32
+ kawasaki,Cycling monocyte (Ye 2026),KD_before - KD_after,2.6128784313341473,4.684374366215975,0.2512150570122724,0.02039983680130559,167 / 5923,179 / 4004,14 / 4450,1 / 2679,-2.0714959348818276,0.23081522021096684,False
33
+ kawasaki,ISG-high monocyte (positive control),KD_before - HC,11.906711239798613,29.233474586603407,1.274849192222572,0.9775801793585651,624 / 5923,332 / 1123,82 / 4450,8 / 798,-17.326763346804796,0.29726901286400687,False
34
+ kawasaki,ISG-high monocyte (positive control),KD_before - KD_after,11.906711239798613,25.277050428993192,1.274849192222572,7.823962048217581,624 / 5923,1855 / 4004,82 / 4450,355 / 2679,-13.37033918919458,-6.549112855995009,True
35
+ kawasaki,ISG-high T,KD_before - HC,0.9911938223128102,3.538188631402496,0.09190895409198184,0.0575576742967665,163 / 16366,352 / 10135,13 / 13373,5 / 9110,-2.5469948090896857,0.034351279795215336,False
36
+ kawasaki,ISG-high T,KD_before - KD_after,0.9911938223128102,8.06264168593457,0.09190895409198184,0.7718234503302432,163 / 16366,1846 / 30531,13 / 13373,143 / 19925,-7.071447863621761,-0.6799144962382614,True
37
+ kawasaki,DN2 / ABC B,KD_before - HC,2.32596714162881,2.6979910423809024,0.654923992476216,0.5704719923687903,223 / 11634,83 / 3316,74 / 11002,24 / 4266,-0.37202390075209246,0.0844520001074257,False
38
+ kawasaki,DN2 / ABC B,KD_before - KD_after,2.32596714162881,1.8164222785066884,0.654923992476216,0.9221791887804214,223 / 11634,107 / 6567,74 / 11002,51 / 5730,0.5095448631221215,-0.26725519630420536,False
39
+ kawasaki,HSPC,KD_before - HC,0.18134899014752195,0.061701458843245925,0.10333333333333335,0.006666666666666667,64 / 36717,10 / 16203,31 / 30000,1 / 15000,0.11964753130427602,0.09666666666666668,True
40
+ kawasaki,HSPC,KD_before - KD_after,0.18134899014752195,0.09833300355722778,0.10333333333333335,0.05333333333333334,64 / 36717,50 / 50442,31 / 30000,16 / 30000,0.08301598659029417,0.05000000000000001,True
41
+ kawasaki,Cytotoxic CD4 T,KD_before - HC,0.09993730706102773,0.5486236128065034,0.6357245082821553,0.6598870534883186,8 / 8948,27 / 4852,48 / 8516,30 / 4764,-0.4486863057454757,-0.024162545206163233,True
42
+ kawasaki,Cytotoxic CD4 T,KD_before - KD_after,0.09993730706102773,0.7729932560621803,0.6357245082821553,0.6631050719128663,8 / 8948,112 / 15056,48 / 8516,75 / 13306,-0.6730559490011525,-0.027380563630710952,True
43
+ kawasaki,Granulocyte-like (LDG),KD_before - HC,5.473569900882143,0.44171443675321626,0.03333333333333333,0.0,1646 / 36717,72 / 16203,10 / 30000,0 / 15000,5.031855464128927,0.03333333333333333,True
44
+ kawasaki,Granulocyte-like (LDG),KD_before - KD_after,5.473569900882143,2.679062920976546,0.03333333333333333,0.02,1646 / 36717,1256 / 50442,10 / 30000,6 / 30000,2.7945069799055964,0.013333333333333332,True
45
+ kawasaki,Platelet signal in monocytes (negative control),KD_before - HC,5.264208789952107,9.010247393520114,1.1888976397532593,0.74859401124791,395 / 5923,84 / 1123,57 / 4450,7 / 798,-3.7460386035680067,0.4403036285053493,False
46
+ kawasaki,Platelet signal in monocytes (negative control),KD_before - KD_after,5.264208789952107,8.990574983487813,1.1888976397532593,1.410177448791105,395 / 5923,390 / 4004,57 / 4450,34 / 2679,-3.7263661935357053,-0.2212798090378456,True
47
+ sle,C1Q-high monocyte (reference),aSLE - aHD,3.3863236923619984,1.810299771748128,0.6235967083522614,0.7264368510629726,347 / 9639,111 / 6619,21 / 3390,7 / 1665,1.5760239206138704,-0.10284014271071118,False
48
+ sle,C1Q-high monocyte (reference),cSLE - cHD,2.273165046807633,1.697982423101878,0.5407014552349637,0.426870356715018,1225 / 45551,117 / 9092,77 / 14947,4 / 1831,0.5751826237057549,0.11383109851994572,True
49
+ sle,Cycling T/NK,aSLE - aHD,0.837945605360791,0.2561005948547752,1.0669833693055693,0.15444522751778383,170 / 22600,74 / 31116,172 / 16370,18 / 11915,0.5818450105060158,0.9125381417877854,True
50
+ sle,Cycling T/NK,cSLE - cHD,1.2736784226396172,0.2162252173758473,0.6853548752697564,0.0893112131404409,1166 / 121357,143 / 63919,475 / 70441,23 / 26119,1.05745320526377,0.5960436621293155,True
51
+ sle,Cycling activated T (CD38/HLA-DR),aSLE - aHD,2.2628602647310596,0.7409402110371681,0.9449272534798411,0.11154036271813475,416 / 20730,187 / 27704,103 / 12979,12 / 10265,1.5219200536938915,0.8333868907617064,True
52
+ sle,Cycling activated T (CD38/HLA-DR),cSLE - cHD,2.3726358457468293,0.8251404658517469,0.5014787309199925,0.043339343885946985,2060 / 111977,470 / 56080,274 / 60156,10 / 23121,1.5474953798950823,0.45813938703404555,True
53
+ sle,Proliferating T (label),aSLE - aHD,1.3708986046051823,0.2534686154336999,0.990682410357999,0.13759616253745005,235 / 20730,69 / 27704,108 / 12979,13 / 10265,1.1174299891714825,0.853086247820549,True
54
+ sle,Proliferating T (label),cSLE - cHD,2.0527491030841025,0.20965210952097363,0.7927259653769708,0.06110365057297782,1532 / 111977,117 / 56080,426 / 60156,14 / 23121,1.843096993563129,0.731622314803993,True
55
+ sle,Plasmablast (label),aSLE - aHD,0.36552998543016224,0.1808309891499833,0.014285714285714287,0.04,143 / 35392,77 / 41440,3 / 21000,6 / 15000,0.18469899628017894,-0.025714285714285714,False
56
+ sle,Plasmablast (label),cSLE - cHD,0.6485051539507586,0.26316099264685144,0.06969696969696969,0.021212121212121213,1084 / 195838,222 / 85565,69 / 99000,7 / 33000,0.38534416130390714,0.04848484848484848,True
57
+ sle,Plasmablast (markers),aSLE - aHD,0.6142704230512808,0.34592185251877805,0.02380952380952381,0.04666666666666667,235 / 35392,140 / 41440,5 / 21000,7 / 15000,0.2683485705325027,-0.022857142857142857,False
58
+ sle,Plasmablast (markers),cSLE - cHD,1.4610093016458972,0.5128511382653218,0.07272727272727272,0.024242424242424242,2434 / 195838,441 / 85565,72 / 99000,8 / 33000,0.9481581633805753,0.04848484848484848,True
59
+ sle,MS1 monocyte (IL1R2+),aSLE - aHD,0.844388384896661,0.4264623316853802,0.06697568786155861,0.026143790849673203,81 / 9639,38 / 6619,3 / 3390,1 / 1665,0.4179260532112808,0.0408318970118854,True
60
+ sle,MS1 monocyte (IL1R2+),cSLE - cHD,3.668409819328916,0.6293328976788833,0.1694438238178471,0.0,2938 / 45551,48 / 9092,17 / 14947,0 / 1831,3.0390769216500324,0.1694438238178471,True
61
+ sle,Cycling monocyte (Ye 2026),aSLE - aHD,1.6523731890242779,0.6380059886935682,0.0,0.0,156 / 9639,46 / 6619,0 / 3390,0 / 1665,1.0143672003307098,0.0,False
62
+ sle,Cycling monocyte (Ye 2026),cSLE - cHD,2.0219382098060517,0.9972697313154367,0.04069807416882908,0.0,912 / 45551,86 / 9092,7 / 14947,0 / 1831,1.0246684784906148,0.04069807416882908,True
63
+ sle,ISG-high monocyte (positive control),aSLE - aHD,44.016416096276025,4.961602874888437,30.369706203047706,2.759272495771859,4069 / 9639,253 / 6619,1175 / 3390,38 / 1665,39.05481322138759,27.610433707275845,True
64
+ sle,ISG-high monocyte (positive control),cSLE - cHD,49.0174918547915,7.289472181082264,35.43010178050385,3.005870663910282,22819 / 45551,574 / 9092,6103 / 14947,56 / 1831,41.72801967370924,32.42423111659357,True
65
+ sle,ISG-high T,aSLE - aHD,22.185704289201755,0.5939462215207182,6.800440857478037,0.26543980240755943,3767 / 20730,175 / 27704,746 / 12979,29 / 10265,21.591758067681038,6.535001055070477,True
66
+ sle,ISG-high T,cSLE - cHD,24.72657410515484,0.8239619972278849,9.705942777236519,0.24134436811234303,21953 / 111977,450 / 56080,4989 / 60156,55 / 23121,23.902612107926956,9.464598409124177,True
67
+ sle,DN2 / ABC B,aSLE - aHD,3.9222477099505784,1.0037814739015367,0.2975917781118304,0.20887166236003446,30 / 936,23 / 2442,3 / 911,2 / 1221,2.9184662360490417,0.08872011575179595,True
68
+ sle,DN2 / ABC B,cSLE - cHD,4.1990145145843325,1.3531158663741683,0.19296510779858136,0.30821039679279855,745 / 21628,133 / 10482,21 / 12436,14 / 4743,2.8458986482101643,-0.11524528899421718,False
69
+ sle,HSPC,aSLE - aHD,0.09953905644652997,0.12294196056529812,0.014285714285714287,0.0,37 / 35392,48 / 41440,3 / 21000,0 / 15000,-0.02340290411876815,0.014285714285714287,False
70
+ sle,HSPC,cSLE - cHD,0.06345381927136531,0.0689047303704229,0.009090909090909092,0.0,123 / 195838,57 / 85565,9 / 99000,0 / 33000,-0.005450911099057584,0.009090909090909092,False
71
+ sle,Cytotoxic CD4 T,aSLE - aHD,3.522706728937545,1.2371276032486498,1.993827530372665,1.493710732543851,187 / 9990,141 / 17255,127 / 7915,100 / 7211,2.285579125688895,0.5001167978288139,True
72
+ sle,Cytotoxic CD4 T,cSLE - cHD,2.9370761906899667,1.9426232376796633,1.105935389491847,1.0136379044644206,1017 / 51287,510 / 27662,408 / 39554,156 / 16876,0.9944529530103035,0.09229748502742652,True
73
+ sle,Granulocyte-like (LDG),aSLE - aHD,0.8396438036327891,0.5061573194800925,0.014285714285714287,0.0,284 / 35392,197 / 41440,3 / 21000,0 / 15000,0.33348648415269666,0.014285714285714287,True
74
+ sle,Granulocyte-like (LDG),cSLE - cHD,0.8878630520415389,0.3400354194934044,0.013131313131313133,0.0030303030303030303,1899 / 195838,317 / 85565,13 / 99000,1 / 33000,0.5478276325481346,0.010101010101010102,True
75
+ sle,Platelet signal in monocytes (negative control),aSLE - aHD,6.128469024723325,2.684595322510098,1.887533541900259,1.1036889332003987,605 / 9639,186 / 6619,66 / 3390,31 / 1665,3.4438737022132266,0.7838446086998603,True
76
+ sle,Platelet signal in monocytes (negative control),cSLE - cHD,5.018032150144058,6.473367720020068,1.6818340894373895,0.844437422368027,2235 / 45551,613 / 9092,286 / 14947,20 / 1831,-1.4553355698760102,0.8373966670693626,False
paper-releases/pbisc-diffusion/updates/20261004T165054Z-rare-states-screen/diffusion/dataset/server_1/model8/plans/rare_states_screen_20261004/out/corpus_states.csv ADDED
@@ -0,0 +1,331 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ dataset_id,state,parent_cells,missing_genes,state_cells,pct
2
+ 001_A_collection_436154da-bcf1-4130-9c8b-120ff9a888_Perez_et_al._lupus_PBMC_cell-type-specific_molecular_genetic_associations_to_lup,C1Q-high monocyte (reference),2555,,44,1.7221135029354206
3
+ 001_A_collection_436154da-bcf1-4130-9c8b-120ff9a888_Perez_et_al._lupus_PBMC_cell-type-specific_molecular_genetic_associations_to_lup,Cycling T/NK,4960,,0,0.0
4
+ 001_A_collection_436154da-bcf1-4130-9c8b-120ff9a888_Perez_et_al._lupus_PBMC_cell-type-specific_molecular_genetic_associations_to_lup,Cycling activated T (CD38/HLA-DR),4268,,36,0.8434864104967198
5
+ 001_A_collection_436154da-bcf1-4130-9c8b-120ff9a888_Perez_et_al._lupus_PBMC_cell-type-specific_molecular_genetic_associations_to_lup,Proliferating T (label),4268,,51,1.1949390815370198
6
+ 001_A_collection_436154da-bcf1-4130-9c8b-120ff9a888_Perez_et_al._lupus_PBMC_cell-type-specific_molecular_genetic_associations_to_lup,Plasmablast (label),9000,,14,0.15555555555555556
7
+ 001_A_collection_436154da-bcf1-4130-9c8b-120ff9a888_Perez_et_al._lupus_PBMC_cell-type-specific_molecular_genetic_associations_to_lup,Plasmablast (markers),9000,,79,0.8777777777777778
8
+ 001_A_collection_436154da-bcf1-4130-9c8b-120ff9a888_Perez_et_al._lupus_PBMC_cell-type-specific_molecular_genetic_associations_to_lup,MS1 monocyte (IL1R2+),2555,,36,1.4090019569471623
9
+ 001_A_collection_436154da-bcf1-4130-9c8b-120ff9a888_Perez_et_al._lupus_PBMC_cell-type-specific_molecular_genetic_associations_to_lup,Cycling monocyte (Ye 2026),2555,,23,0.9001956947162426
10
+ 001_A_collection_436154da-bcf1-4130-9c8b-120ff9a888_Perez_et_al._lupus_PBMC_cell-type-specific_molecular_genetic_associations_to_lup,ISG-high monocyte (positive control),2555,,591,23.131115459882583
11
+ 001_A_collection_436154da-bcf1-4130-9c8b-120ff9a888_Perez_et_al._lupus_PBMC_cell-type-specific_molecular_genetic_associations_to_lup,ISG-high T,4268,,163,3.8191190253045924
12
+ 001_A_collection_436154da-bcf1-4130-9c8b-120ff9a888_Perez_et_al._lupus_PBMC_cell-type-specific_molecular_genetic_associations_to_lup,DN2 / ABC B,1085,,13,1.1981566820276497
13
+ 001_A_collection_436154da-bcf1-4130-9c8b-120ff9a888_Perez_et_al._lupus_PBMC_cell-type-specific_molecular_genetic_associations_to_lup,HSPC,9000,,5,0.05555555555555555
14
+ 001_A_collection_436154da-bcf1-4130-9c8b-120ff9a888_Perez_et_al._lupus_PBMC_cell-type-specific_molecular_genetic_associations_to_lup,Cytotoxic CD4 T,2307,,26,1.1270047680970958
15
+ 001_A_collection_436154da-bcf1-4130-9c8b-120ff9a888_Perez_et_al._lupus_PBMC_cell-type-specific_molecular_genetic_associations_to_lup,Granulocyte-like (LDG),9000,,47,0.5222222222222223
16
+ 001_A_collection_436154da-bcf1-4130-9c8b-120ff9a888_Perez_et_al._lupus_PBMC_cell-type-specific_molecular_genetic_associations_to_lup,Platelet signal in monocytes (negative control),2555,,192,7.514677103718199
17
+ 005_A_collection_dde06e0f-ab3b-46be-96a2-a8082383c4_OneK1K_Yazar_et_al._single-cell_eQTL_mapping,C1Q-high monocyte (reference),305,,6,1.9672131147540983
18
+ 005_A_collection_dde06e0f-ab3b-46be-96a2-a8082383c4_OneK1K_Yazar_et_al._single-cell_eQTL_mapping,Cycling T/NK,7317,,17,0.23233565668990022
19
+ 005_A_collection_dde06e0f-ab3b-46be-96a2-a8082383c4_OneK1K_Yazar_et_al._single-cell_eQTL_mapping,Cycling activated T (CD38/HLA-DR),6187,,23,0.37174721189591076
20
+ 005_A_collection_dde06e0f-ab3b-46be-96a2-a8082383c4_OneK1K_Yazar_et_al._single-cell_eQTL_mapping,Proliferating T (label),6187,,60,0.9697753353806369
21
+ 005_A_collection_dde06e0f-ab3b-46be-96a2-a8082383c4_OneK1K_Yazar_et_al._single-cell_eQTL_mapping,Plasmablast (label),8750,,27,0.30857142857142855
22
+ 005_A_collection_dde06e0f-ab3b-46be-96a2-a8082383c4_OneK1K_Yazar_et_al._single-cell_eQTL_mapping,Plasmablast (markers),8750,IGLL5,42,0.48
23
+ 005_A_collection_dde06e0f-ab3b-46be-96a2-a8082383c4_OneK1K_Yazar_et_al._single-cell_eQTL_mapping,MS1 monocyte (IL1R2+),305,,2,0.6557377049180327
24
+ 005_A_collection_dde06e0f-ab3b-46be-96a2-a8082383c4_OneK1K_Yazar_et_al._single-cell_eQTL_mapping,Cycling monocyte (Ye 2026),305,,4,1.3114754098360655
25
+ 005_A_collection_dde06e0f-ab3b-46be-96a2-a8082383c4_OneK1K_Yazar_et_al._single-cell_eQTL_mapping,ISG-high monocyte (positive control),305,,32,10.491803278688524
26
+ 005_A_collection_dde06e0f-ab3b-46be-96a2-a8082383c4_OneK1K_Yazar_et_al._single-cell_eQTL_mapping,ISG-high T,6187,,47,0.7596573460481655
27
+ 005_A_collection_dde06e0f-ab3b-46be-96a2-a8082383c4_OneK1K_Yazar_et_al._single-cell_eQTL_mapping,DN2 / ABC B,1031,,22,2.133850630455868
28
+ 005_A_collection_dde06e0f-ab3b-46be-96a2-a8082383c4_OneK1K_Yazar_et_al._single-cell_eQTL_mapping,HSPC,8750,,13,0.14857142857142858
29
+ 005_A_collection_dde06e0f-ab3b-46be-96a2-a8082383c4_OneK1K_Yazar_et_al._single-cell_eQTL_mapping,Cytotoxic CD4 T,4062,,76,1.8709995076317085
30
+ 005_A_collection_dde06e0f-ab3b-46be-96a2-a8082383c4_OneK1K_Yazar_et_al._single-cell_eQTL_mapping,Granulocyte-like (LDG),8750,,15,0.17142857142857143
31
+ 005_A_collection_dde06e0f-ab3b-46be-96a2-a8082383c4_OneK1K_Yazar_et_al._single-cell_eQTL_mapping,Platelet signal in monocytes (negative control),305,,24,7.868852459016393
32
+ 006_A_collection_ced320a1-29f3-47c1-a735-513c7084d5_AIDA_Asian_Immune_Diversity_Atlas,C1Q-high monocyte (reference),1413,,34,2.4062278839348905
33
+ 006_A_collection_ced320a1-29f3-47c1-a735-513c7084d5_AIDA_Asian_Immune_Diversity_Atlas,Cycling T/NK,6693,,6,0.08964589870013447
34
+ 006_A_collection_ced320a1-29f3-47c1-a735-513c7084d5_AIDA_Asian_Immune_Diversity_Atlas,Cycling activated T (CD38/HLA-DR),5814,,68,1.1695906432748537
35
+ 006_A_collection_ced320a1-29f3-47c1-a735-513c7084d5_AIDA_Asian_Immune_Diversity_Atlas,Proliferating T (label),5814,,12,0.20639834881320948
36
+ 006_A_collection_ced320a1-29f3-47c1-a735-513c7084d5_AIDA_Asian_Immune_Diversity_Atlas,Plasmablast (label),9000,,0,0.0
37
+ 006_A_collection_ced320a1-29f3-47c1-a735-513c7084d5_AIDA_Asian_Immune_Diversity_Atlas,Plasmablast (markers),9000,IGLL5,100,1.1111111111111112
38
+ 006_A_collection_ced320a1-29f3-47c1-a735-513c7084d5_AIDA_Asian_Immune_Diversity_Atlas,MS1 monocyte (IL1R2+),1413,,13,0.9200283085633404
39
+ 006_A_collection_ced320a1-29f3-47c1-a735-513c7084d5_AIDA_Asian_Immune_Diversity_Atlas,Cycling monocyte (Ye 2026),1413,,25,1.7692852087756545
40
+ 006_A_collection_ced320a1-29f3-47c1-a735-513c7084d5_AIDA_Asian_Immune_Diversity_Atlas,ISG-high monocyte (positive control),1413,,280,19.815994338287332
41
+ 006_A_collection_ced320a1-29f3-47c1-a735-513c7084d5_AIDA_Asian_Immune_Diversity_Atlas,ISG-high T,5814,,117,2.0123839009287927
42
+ 006_A_collection_ced320a1-29f3-47c1-a735-513c7084d5_AIDA_Asian_Immune_Diversity_Atlas,DN2 / ABC B,767,,46,5.9973924380704045
43
+ 006_A_collection_ced320a1-29f3-47c1-a735-513c7084d5_AIDA_Asian_Immune_Diversity_Atlas,HSPC,9000,,1,0.011111111111111112
44
+ 006_A_collection_ced320a1-29f3-47c1-a735-513c7084d5_AIDA_Asian_Immune_Diversity_Atlas,Cytotoxic CD4 T,2790,,62,2.2222222222222223
45
+ 006_A_collection_ced320a1-29f3-47c1-a735-513c7084d5_AIDA_Asian_Immune_Diversity_Atlas,Granulocyte-like (LDG),9000,,155,1.7222222222222223
46
+ 006_A_collection_ced320a1-29f3-47c1-a735-513c7084d5_AIDA_Asian_Immune_Diversity_Atlas,Platelet signal in monocytes (negative control),1413,,198,14.012738853503185
47
+ 007_A_collection_e1a9ca56-f2ee-435d-980a-4f49ab7a95_Miao_et_al._RA_PBMC_disease_activity-associated_PBMC_subsets,C1Q-high monocyte (reference),734,,3,0.4087193460490463
48
+ 007_A_collection_e1a9ca56-f2ee-435d-980a-4f49ab7a95_Miao_et_al._RA_PBMC_disease_activity-associated_PBMC_subsets,Cycling T/NK,3960,,4,0.10101010101010101
49
+ 007_A_collection_e1a9ca56-f2ee-435d-980a-4f49ab7a95_Miao_et_al._RA_PBMC_disease_activity-associated_PBMC_subsets,Cycling activated T (CD38/HLA-DR),3613,,2,0.05535566011624689
50
+ 007_A_collection_e1a9ca56-f2ee-435d-980a-4f49ab7a95_Miao_et_al._RA_PBMC_disease_activity-associated_PBMC_subsets,Proliferating T (label),3613,,7,0.19374481040686412
51
+ 007_A_collection_e1a9ca56-f2ee-435d-980a-4f49ab7a95_Miao_et_al._RA_PBMC_disease_activity-associated_PBMC_subsets,Plasmablast (label),8000,,3,0.0375
52
+ 007_A_collection_e1a9ca56-f2ee-435d-980a-4f49ab7a95_Miao_et_al._RA_PBMC_disease_activity-associated_PBMC_subsets,Plasmablast (markers),8000,,7,0.0875
53
+ 007_A_collection_e1a9ca56-f2ee-435d-980a-4f49ab7a95_Miao_et_al._RA_PBMC_disease_activity-associated_PBMC_subsets,MS1 monocyte (IL1R2+),734,,0,0.0
54
+ 007_A_collection_e1a9ca56-f2ee-435d-980a-4f49ab7a95_Miao_et_al._RA_PBMC_disease_activity-associated_PBMC_subsets,Cycling monocyte (Ye 2026),734,,1,0.1362397820163488
55
+ 007_A_collection_e1a9ca56-f2ee-435d-980a-4f49ab7a95_Miao_et_al._RA_PBMC_disease_activity-associated_PBMC_subsets,ISG-high monocyte (positive control),734,,14,1.9073569482288828
56
+ 007_A_collection_e1a9ca56-f2ee-435d-980a-4f49ab7a95_Miao_et_al._RA_PBMC_disease_activity-associated_PBMC_subsets,ISG-high T,3613,,1,0.027677830058123444
57
+ 007_A_collection_e1a9ca56-f2ee-435d-980a-4f49ab7a95_Miao_et_al._RA_PBMC_disease_activity-associated_PBMC_subsets,DN2 / ABC B,350,,2,0.5714285714285714
58
+ 007_A_collection_e1a9ca56-f2ee-435d-980a-4f49ab7a95_Miao_et_al._RA_PBMC_disease_activity-associated_PBMC_subsets,HSPC,8000,,0,0.0
59
+ 007_A_collection_e1a9ca56-f2ee-435d-980a-4f49ab7a95_Miao_et_al._RA_PBMC_disease_activity-associated_PBMC_subsets,Cytotoxic CD4 T,1236,,0,0.0
60
+ 007_A_collection_e1a9ca56-f2ee-435d-980a-4f49ab7a95_Miao_et_al._RA_PBMC_disease_activity-associated_PBMC_subsets,Granulocyte-like (LDG),8000,MPO CTSG,3,0.0375
61
+ 007_A_collection_e1a9ca56-f2ee-435d-980a-4f49ab7a95_Miao_et_al._RA_PBMC_disease_activity-associated_PBMC_subsets,Platelet signal in monocytes (negative control),734,PPBP PF4,1,0.1362397820163488
62
+ 009_A_Human_Immune_Health_Atlas_Human_Immune_Health_Atlas_AIFI_immune_dynamics_across_healthy_age,C1Q-high monocyte (reference),1310,,13,0.9923664122137404
63
+ 009_A_Human_Immune_Health_Atlas_Human_Immune_Health_Atlas_AIFI_immune_dynamics_across_healthy_age,Cycling T/NK,5756,,18,0.3127171646977067
64
+ 009_A_Human_Immune_Health_Atlas_Human_Immune_Health_Atlas_AIFI_immune_dynamics_across_healthy_age,Cycling activated T (CD38/HLA-DR),5153,,49,0.9509023869590529
65
+ 009_A_Human_Immune_Health_Atlas_Human_Immune_Health_Atlas_AIFI_immune_dynamics_across_healthy_age,Proliferating T (label),5153,,27,0.5239666213856006
66
+ 009_A_Human_Immune_Health_Atlas_Human_Immune_Health_Atlas_AIFI_immune_dynamics_across_healthy_age,Plasmablast (label),8000,,7,0.0875
67
+ 009_A_Human_Immune_Health_Atlas_Human_Immune_Health_Atlas_AIFI_immune_dynamics_across_healthy_age,Plasmablast (markers),8000,,48,0.6
68
+ 009_A_Human_Immune_Health_Atlas_Human_Immune_Health_Atlas_AIFI_immune_dynamics_across_healthy_age,MS1 monocyte (IL1R2+),1310,,11,0.8396946564885496
69
+ 009_A_Human_Immune_Health_Atlas_Human_Immune_Health_Atlas_AIFI_immune_dynamics_across_healthy_age,Cycling monocyte (Ye 2026),1310,,16,1.2213740458015268
70
+ 009_A_Human_Immune_Health_Atlas_Human_Immune_Health_Atlas_AIFI_immune_dynamics_across_healthy_age,ISG-high monocyte (positive control),1310,,297,22.671755725190838
71
+ 009_A_Human_Immune_Health_Atlas_Human_Immune_Health_Atlas_AIFI_immune_dynamics_across_healthy_age,ISG-high T,5153,,92,1.785367746943528
72
+ 009_A_Human_Immune_Health_Atlas_Human_Immune_Health_Atlas_AIFI_immune_dynamics_across_healthy_age,DN2 / ABC B,794,,10,1.2594458438287153
73
+ 009_A_Human_Immune_Health_Atlas_Human_Immune_Health_Atlas_AIFI_immune_dynamics_across_healthy_age,HSPC,8000,,11,0.1375
74
+ 009_A_Human_Immune_Health_Atlas_Human_Immune_Health_Atlas_AIFI_immune_dynamics_across_healthy_age,Cytotoxic CD4 T,3099,,37,1.1939335269441755
75
+ 009_A_Human_Immune_Health_Atlas_Human_Immune_Health_Atlas_AIFI_immune_dynamics_across_healthy_age,Granulocyte-like (LDG),8000,,121,1.5125
76
+ 009_A_Human_Immune_Health_Atlas_Human_Immune_Health_Atlas_AIFI_immune_dynamics_across_healthy_age,Platelet signal in monocytes (negative control),1310,,69,5.267175572519084
77
+ 010_A_collection_4a9fd4d7-d870-4265-89a5-ad51ab811d_ScaleBio_single-cell_RNA_sequencing_of_human_PBMCs,C1Q-high monocyte (reference),1491,,6,0.4024144869215292
78
+ 010_A_collection_4a9fd4d7-d870-4265-89a5-ad51ab811d_ScaleBio_single-cell_RNA_sequencing_of_human_PBMCs,Cycling T/NK,5149,,19,0.36900369003690037
79
+ 010_A_collection_4a9fd4d7-d870-4265-89a5-ad51ab811d_ScaleBio_single-cell_RNA_sequencing_of_human_PBMCs,Cycling activated T (CD38/HLA-DR),4533,,34,0.7500551511140525
80
+ 010_A_collection_4a9fd4d7-d870-4265-89a5-ad51ab811d_ScaleBio_single-cell_RNA_sequencing_of_human_PBMCs,Proliferating T (label),4533,,54,1.1912640635340834
81
+ 010_A_collection_4a9fd4d7-d870-4265-89a5-ad51ab811d_ScaleBio_single-cell_RNA_sequencing_of_human_PBMCs,Plasmablast (label),8250,,13,0.15757575757575756
82
+ 010_A_collection_4a9fd4d7-d870-4265-89a5-ad51ab811d_ScaleBio_single-cell_RNA_sequencing_of_human_PBMCs,Plasmablast (markers),8250,,34,0.4121212121212121
83
+ 010_A_collection_4a9fd4d7-d870-4265-89a5-ad51ab811d_ScaleBio_single-cell_RNA_sequencing_of_human_PBMCs,MS1 monocyte (IL1R2+),1491,,5,0.335345405767941
84
+ 010_A_collection_4a9fd4d7-d870-4265-89a5-ad51ab811d_ScaleBio_single-cell_RNA_sequencing_of_human_PBMCs,Cycling monocyte (Ye 2026),1491,,31,2.079141515761234
85
+ 010_A_collection_4a9fd4d7-d870-4265-89a5-ad51ab811d_ScaleBio_single-cell_RNA_sequencing_of_human_PBMCs,ISG-high monocyte (positive control),1491,,67,4.493628437290409
86
+ 010_A_collection_4a9fd4d7-d870-4265-89a5-ad51ab811d_ScaleBio_single-cell_RNA_sequencing_of_human_PBMCs,ISG-high T,4533,,10,0.22060445621001545
87
+ 010_A_collection_4a9fd4d7-d870-4265-89a5-ad51ab811d_ScaleBio_single-cell_RNA_sequencing_of_human_PBMCs,DN2 / ABC B,1527,,30,1.9646365422396856
88
+ 010_A_collection_4a9fd4d7-d870-4265-89a5-ad51ab811d_ScaleBio_single-cell_RNA_sequencing_of_human_PBMCs,HSPC,8250,,0,0.0
89
+ 010_A_collection_4a9fd4d7-d870-4265-89a5-ad51ab811d_ScaleBio_single-cell_RNA_sequencing_of_human_PBMCs,Cytotoxic CD4 T,2510,,0,0.0
90
+ 010_A_collection_4a9fd4d7-d870-4265-89a5-ad51ab811d_ScaleBio_single-cell_RNA_sequencing_of_human_PBMCs,Granulocyte-like (LDG),8250,LCN2,82,0.9939393939393939
91
+ 010_A_collection_4a9fd4d7-d870-4265-89a5-ad51ab811d_ScaleBio_single-cell_RNA_sequencing_of_human_PBMCs,Platelet signal in monocytes (negative control),1491,,9,0.6036217303822937
92
+ 053_B_collection_b0cf0afa-ec40-4d65-b570-ed4ceacc68_Integrated_analysis_of_multimodal_single-cell_data_CITE-seq_PBMC,C1Q-high monocyte (reference),2491,,67,2.6896828582898435
93
+ 053_B_collection_b0cf0afa-ec40-4d65-b570-ed4ceacc68_Integrated_analysis_of_multimodal_single-cell_data_CITE-seq_PBMC,Cycling T/NK,4430,,38,0.8577878103837472
94
+ 053_B_collection_b0cf0afa-ec40-4d65-b570-ed4ceacc68_Integrated_analysis_of_multimodal_single-cell_data_CITE-seq_PBMC,Cycling activated T (CD38/HLA-DR),3508,,100,2.8506271379703536
95
+ 053_B_collection_b0cf0afa-ec40-4d65-b570-ed4ceacc68_Integrated_analysis_of_multimodal_single-cell_data_CITE-seq_PBMC,Proliferating T (label),3508,,21,0.5986316989737742
96
+ 053_B_collection_b0cf0afa-ec40-4d65-b570-ed4ceacc68_Integrated_analysis_of_multimodal_single-cell_data_CITE-seq_PBMC,Plasmablast (label),8000,,20,0.25
97
+ 053_B_collection_b0cf0afa-ec40-4d65-b570-ed4ceacc68_Integrated_analysis_of_multimodal_single-cell_data_CITE-seq_PBMC,Plasmablast (markers),8000,,162,2.025
98
+ 053_B_collection_b0cf0afa-ec40-4d65-b570-ed4ceacc68_Integrated_analysis_of_multimodal_single-cell_data_CITE-seq_PBMC,MS1 monocyte (IL1R2+),2491,,35,1.4050582095543958
99
+ 053_B_collection_b0cf0afa-ec40-4d65-b570-ed4ceacc68_Integrated_analysis_of_multimodal_single-cell_data_CITE-seq_PBMC,Cycling monocyte (Ye 2026),2491,,138,5.539943797671618
100
+ 053_B_collection_b0cf0afa-ec40-4d65-b570-ed4ceacc68_Integrated_analysis_of_multimodal_single-cell_data_CITE-seq_PBMC,ISG-high monocyte (positive control),2491,,1143,45.885186672019266
101
+ 053_B_collection_b0cf0afa-ec40-4d65-b570-ed4ceacc68_Integrated_analysis_of_multimodal_single-cell_data_CITE-seq_PBMC,ISG-high T,3508,,119,3.3922462941847207
102
+ 053_B_collection_b0cf0afa-ec40-4d65-b570-ed4ceacc68_Integrated_analysis_of_multimodal_single-cell_data_CITE-seq_PBMC,DN2 / ABC B,728,,50,6.868131868131868
103
+ 053_B_collection_b0cf0afa-ec40-4d65-b570-ed4ceacc68_Integrated_analysis_of_multimodal_single-cell_data_CITE-seq_PBMC,HSPC,8000,,14,0.175
104
+ 053_B_collection_b0cf0afa-ec40-4d65-b570-ed4ceacc68_Integrated_analysis_of_multimodal_single-cell_data_CITE-seq_PBMC,Cytotoxic CD4 T,1819,,86,4.727872457394173
105
+ 053_B_collection_b0cf0afa-ec40-4d65-b570-ed4ceacc68_Integrated_analysis_of_multimodal_single-cell_data_CITE-seq_PBMC,Granulocyte-like (LDG),8000,,411,5.1375
106
+ 053_B_collection_b0cf0afa-ec40-4d65-b570-ed4ceacc68_Integrated_analysis_of_multimodal_single-cell_data_CITE-seq_PBMC,Platelet signal in monocytes (negative control),2491,,403,16.178241670012042
107
+ 058_B_collection_eb735cc9-d0a7-48fa-b255-db726bf365_COVID_PBMC_nasal_swab_donors_with_immunodeficiencies_and_autoimmune_conditions,C1Q-high monocyte (reference),2448,,64,2.6143790849673203
108
+ 058_B_collection_eb735cc9-d0a7-48fa-b255-db726bf365_COVID_PBMC_nasal_swab_donors_with_immunodeficiencies_and_autoimmune_conditions,Cycling T/NK,4197,,95,2.2635215630212056
109
+ 058_B_collection_eb735cc9-d0a7-48fa-b255-db726bf365_COVID_PBMC_nasal_swab_donors_with_immunodeficiencies_and_autoimmune_conditions,Cycling activated T (CD38/HLA-DR),3442,,150,4.357931435212086
110
+ 058_B_collection_eb735cc9-d0a7-48fa-b255-db726bf365_COVID_PBMC_nasal_swab_donors_with_immunodeficiencies_and_autoimmune_conditions,Proliferating T (label),3442,,91,2.643811737361999
111
+ 058_B_collection_eb735cc9-d0a7-48fa-b255-db726bf365_COVID_PBMC_nasal_swab_donors_with_immunodeficiencies_and_autoimmune_conditions,Plasmablast (label),8000,,93,1.1625
112
+ 058_B_collection_eb735cc9-d0a7-48fa-b255-db726bf365_COVID_PBMC_nasal_swab_donors_with_immunodeficiencies_and_autoimmune_conditions,Plasmablast (markers),8000,,243,3.0375
113
+ 058_B_collection_eb735cc9-d0a7-48fa-b255-db726bf365_COVID_PBMC_nasal_swab_donors_with_immunodeficiencies_and_autoimmune_conditions,MS1 monocyte (IL1R2+),2448,,646,26.38888888888889
114
+ 058_B_collection_eb735cc9-d0a7-48fa-b255-db726bf365_COVID_PBMC_nasal_swab_donors_with_immunodeficiencies_and_autoimmune_conditions,Cycling monocyte (Ye 2026),2448,,98,4.003267973856209
115
+ 058_B_collection_eb735cc9-d0a7-48fa-b255-db726bf365_COVID_PBMC_nasal_swab_donors_with_immunodeficiencies_and_autoimmune_conditions,ISG-high monocyte (positive control),2448,,390,15.931372549019608
116
+ 058_B_collection_eb735cc9-d0a7-48fa-b255-db726bf365_COVID_PBMC_nasal_swab_donors_with_immunodeficiencies_and_autoimmune_conditions,ISG-high T,3442,,118,3.4282393957001744
117
+ 058_B_collection_eb735cc9-d0a7-48fa-b255-db726bf365_COVID_PBMC_nasal_swab_donors_with_immunodeficiencies_and_autoimmune_conditions,DN2 / ABC B,846,,33,3.900709219858156
118
+ 058_B_collection_eb735cc9-d0a7-48fa-b255-db726bf365_COVID_PBMC_nasal_swab_donors_with_immunodeficiencies_and_autoimmune_conditions,HSPC,8000,,33,0.4125
119
+ 058_B_collection_eb735cc9-d0a7-48fa-b255-db726bf365_COVID_PBMC_nasal_swab_donors_with_immunodeficiencies_and_autoimmune_conditions,Cytotoxic CD4 T,1679,,14,0.8338296605122096
120
+ 058_B_collection_eb735cc9-d0a7-48fa-b255-db726bf365_COVID_PBMC_nasal_swab_donors_with_immunodeficiencies_and_autoimmune_conditions,Granulocyte-like (LDG),8000,,217,2.7125
121
+ 058_B_collection_eb735cc9-d0a7-48fa-b255-db726bf365_COVID_PBMC_nasal_swab_donors_with_immunodeficiencies_and_autoimmune_conditions,Platelet signal in monocytes (negative control),2448,,315,12.867647058823529
122
+ 061_A_GSE274680_Savage_Allen_RA_at-risk_longitudinal_progression_PBMC_multi-omic_cohort,C1Q-high monocyte (reference),1498,,21,1.4018691588785046
123
+ 061_A_GSE274680_Savage_Allen_RA_at-risk_longitudinal_progression_PBMC_multi-omic_cohort,Cycling T/NK,5355,,21,0.39215686274509803
124
+ 061_A_GSE274680_Savage_Allen_RA_at-risk_longitudinal_progression_PBMC_multi-omic_cohort,Cycling activated T (CD38/HLA-DR),4765,,58,1.217208814270724
125
+ 061_A_GSE274680_Savage_Allen_RA_at-risk_longitudinal_progression_PBMC_multi-omic_cohort,Proliferating T (label),4765,,27,0.5666316894018888
126
+ 061_A_GSE274680_Savage_Allen_RA_at-risk_longitudinal_progression_PBMC_multi-omic_cohort,Plasmablast (label),8000,,5,0.0625
127
+ 061_A_GSE274680_Savage_Allen_RA_at-risk_longitudinal_progression_PBMC_multi-omic_cohort,Plasmablast (markers),8000,,87,1.0875
128
+ 061_A_GSE274680_Savage_Allen_RA_at-risk_longitudinal_progression_PBMC_multi-omic_cohort,MS1 monocyte (IL1R2+),1498,,24,1.6021361815754338
129
+ 061_A_GSE274680_Savage_Allen_RA_at-risk_longitudinal_progression_PBMC_multi-omic_cohort,Cycling monocyte (Ye 2026),1498,,23,1.5353805073431241
130
+ 061_A_GSE274680_Savage_Allen_RA_at-risk_longitudinal_progression_PBMC_multi-omic_cohort,ISG-high monocyte (positive control),1498,,240,16.02136181575434
131
+ 061_A_GSE274680_Savage_Allen_RA_at-risk_longitudinal_progression_PBMC_multi-omic_cohort,ISG-high T,4765,,68,1.4270724029380903
132
+ 061_A_GSE274680_Savage_Allen_RA_at-risk_longitudinal_progression_PBMC_multi-omic_cohort,DN2 / ABC B,880,,32,3.6363636363636362
133
+ 061_A_GSE274680_Savage_Allen_RA_at-risk_longitudinal_progression_PBMC_multi-omic_cohort,HSPC,8000,,3,0.0375
134
+ 061_A_GSE274680_Savage_Allen_RA_at-risk_longitudinal_progression_PBMC_multi-omic_cohort,Cytotoxic CD4 T,2643,,56,2.1188043889519483
135
+ 061_A_GSE274680_Savage_Allen_RA_at-risk_longitudinal_progression_PBMC_multi-omic_cohort,Granulocyte-like (LDG),8000,,151,1.8875
136
+ 061_A_GSE274680_Savage_Allen_RA_at-risk_longitudinal_progression_PBMC_multi-omic_cohort,Platelet signal in monocytes (negative control),1498,,131,8.744993324432576
137
+ 065_A_GSE271896_GSE271896_Sound_Life_deep_longitudinal_immune_profiling,C1Q-high monocyte (reference),1797,,15,0.8347245409015025
138
+ 065_A_GSE271896_GSE271896_Sound_Life_deep_longitudinal_immune_profiling,Cycling T/NK,5634,,36,0.6389776357827476
139
+ 065_A_GSE271896_GSE271896_Sound_Life_deep_longitudinal_immune_profiling,Cycling activated T (CD38/HLA-DR),5210,,72,1.381957773512476
140
+ 065_A_GSE271896_GSE271896_Sound_Life_deep_longitudinal_immune_profiling,Proliferating T (label),5210,,50,0.9596928982725528
141
+ 065_A_GSE271896_GSE271896_Sound_Life_deep_longitudinal_immune_profiling,Plasmablast (label),8000,,0,0.0
142
+ 065_A_GSE271896_GSE271896_Sound_Life_deep_longitudinal_immune_profiling,Plasmablast (markers),8000,,15,0.1875
143
+ 065_A_GSE271896_GSE271896_Sound_Life_deep_longitudinal_immune_profiling,MS1 monocyte (IL1R2+),1797,,28,1.5581524763494714
144
+ 065_A_GSE271896_GSE271896_Sound_Life_deep_longitudinal_immune_profiling,Cycling monocyte (Ye 2026),1797,,17,0.9460211463550362
145
+ 065_A_GSE271896_GSE271896_Sound_Life_deep_longitudinal_immune_profiling,ISG-high monocyte (positive control),1797,,463,25.765164162493043
146
+ 065_A_GSE271896_GSE271896_Sound_Life_deep_longitudinal_immune_profiling,ISG-high T,5210,,79,1.5163147792706333
147
+ 065_A_GSE271896_GSE271896_Sound_Life_deep_longitudinal_immune_profiling,DN2 / ABC B,410,,9,2.1951219512195124
148
+ 065_A_GSE271896_GSE271896_Sound_Life_deep_longitudinal_immune_profiling,HSPC,8000,,8,0.1
149
+ 065_A_GSE271896_GSE271896_Sound_Life_deep_longitudinal_immune_profiling,Cytotoxic CD4 T,2297,,19,0.827165868524162
150
+ 065_A_GSE271896_GSE271896_Sound_Life_deep_longitudinal_immune_profiling,Granulocyte-like (LDG),8000,,212,2.65
151
+ 065_A_GSE271896_GSE271896_Sound_Life_deep_longitudinal_immune_profiling,Platelet signal in monocytes (negative control),1797,,108,6.010016694490818
152
+ 071_C_JDM_CITE-seq_PBMC_CELLxGENE_JDM_CITE-seq_PBMC_CELLxGENE,C1Q-high monocyte (reference),1259,,4,0.3177124702144559
153
+ 071_C_JDM_CITE-seq_PBMC_CELLxGENE_JDM_CITE-seq_PBMC_CELLxGENE,Cycling T/NK,5378,,16,0.29750836742283376
154
+ 071_C_JDM_CITE-seq_PBMC_CELLxGENE_JDM_CITE-seq_PBMC_CELLxGENE,Cycling activated T (CD38/HLA-DR),4758,,57,1.1979823455233292
155
+ 071_C_JDM_CITE-seq_PBMC_CELLxGENE_JDM_CITE-seq_PBMC_CELLxGENE,Proliferating T (label),4758,,28,0.5884825556956704
156
+ 071_C_JDM_CITE-seq_PBMC_CELLxGENE_JDM_CITE-seq_PBMC_CELLxGENE,Plasmablast (label),8000,,27,0.3375
157
+ 071_C_JDM_CITE-seq_PBMC_CELLxGENE_JDM_CITE-seq_PBMC_CELLxGENE,Plasmablast (markers),8000,IGLL5,96,1.2
158
+ 071_C_JDM_CITE-seq_PBMC_CELLxGENE_JDM_CITE-seq_PBMC_CELLxGENE,MS1 monocyte (IL1R2+),1259,,136,10.802223987291502
159
+ 071_C_JDM_CITE-seq_PBMC_CELLxGENE_JDM_CITE-seq_PBMC_CELLxGENE,Cycling monocyte (Ye 2026),1259,,30,2.3828435266084194
160
+ 071_C_JDM_CITE-seq_PBMC_CELLxGENE_JDM_CITE-seq_PBMC_CELLxGENE,ISG-high monocyte (positive control),1259,,383,30.420969023034154
161
+ 071_C_JDM_CITE-seq_PBMC_CELLxGENE_JDM_CITE-seq_PBMC_CELLxGENE,ISG-high T,4758,,413,8.68011769651114
162
+ 071_C_JDM_CITE-seq_PBMC_CELLxGENE_JDM_CITE-seq_PBMC_CELLxGENE,DN2 / ABC B,1202,,42,3.4941763727121464
163
+ 071_C_JDM_CITE-seq_PBMC_CELLxGENE_JDM_CITE-seq_PBMC_CELLxGENE,HSPC,8000,,10,0.125
164
+ 071_C_JDM_CITE-seq_PBMC_CELLxGENE_JDM_CITE-seq_PBMC_CELLxGENE,Cytotoxic CD4 T,2819,,11,0.3902092940759134
165
+ 071_C_JDM_CITE-seq_PBMC_CELLxGENE_JDM_CITE-seq_PBMC_CELLxGENE,Granulocyte-like (LDG),8000,,116,1.45
166
+ 071_C_JDM_CITE-seq_PBMC_CELLxGENE_JDM_CITE-seq_PBMC_CELLxGENE,Platelet signal in monocytes (negative control),1259,,154,12.231930103256552
167
+ 074_A_COMBAT_CELLxGENE_collection_COMBAT_CELLxGENE_collection,C1Q-high monocyte (reference),2510,,96,3.8247011952191237
168
+ 074_A_COMBAT_CELLxGENE_collection_COMBAT_CELLxGENE_collection,Cycling T/NK,4766,,135,2.832563994964331
169
+ 074_A_COMBAT_CELLxGENE_collection_COMBAT_CELLxGENE_collection,Cycling activated T (CD38/HLA-DR),4035,,160,3.965303593556382
170
+ 074_A_COMBAT_CELLxGENE_collection_COMBAT_CELLxGENE_collection,Proliferating T (label),4035,,178,4.411400247831475
171
+ 074_A_COMBAT_CELLxGENE_collection_COMBAT_CELLxGENE_collection,Plasmablast (label),8000,,95,1.1875
172
+ 074_A_COMBAT_CELLxGENE_collection_COMBAT_CELLxGENE_collection,Plasmablast (markers),8000,,237,2.9625
173
+ 074_A_COMBAT_CELLxGENE_collection_COMBAT_CELLxGENE_collection,MS1 monocyte (IL1R2+),2510,,291,11.593625498007968
174
+ 074_A_COMBAT_CELLxGENE_collection_COMBAT_CELLxGENE_collection,Cycling monocyte (Ye 2026),2510,,208,8.286852589641434
175
+ 074_A_COMBAT_CELLxGENE_collection_COMBAT_CELLxGENE_collection,ISG-high monocyte (positive control),2510,,882,35.1394422310757
176
+ 074_A_COMBAT_CELLxGENE_collection_COMBAT_CELLxGENE_collection,ISG-high T,4035,,514,12.738537794299877
177
+ 074_A_COMBAT_CELLxGENE_collection_COMBAT_CELLxGENE_collection,DN2 / ABC B,541,,17,3.142329020332717
178
+ 074_A_COMBAT_CELLxGENE_collection_COMBAT_CELLxGENE_collection,HSPC,8000,,16,0.2
179
+ 074_A_COMBAT_CELLxGENE_collection_COMBAT_CELLxGENE_collection,Cytotoxic CD4 T,2475,,30,1.2121212121212122
180
+ 074_A_COMBAT_CELLxGENE_collection_COMBAT_CELLxGENE_collection,Granulocyte-like (LDG),8000,,239,2.9875
181
+ 074_A_COMBAT_CELLxGENE_collection_COMBAT_CELLxGENE_collection,Platelet signal in monocytes (negative control),2510,,28,1.1155378486055776
182
+ 081_B_Single-cell_atlas_of_peripheral_immune_respon_Single-cell_atlas_of_peripheral_immune_response_to_SARS-CoV-2,C1Q-high monocyte (reference),2313,,16,0.6917423259835711
183
+ 081_B_Single-cell_atlas_of_peripheral_immune_respon_Single-cell_atlas_of_peripheral_immune_response_to_SARS-CoV-2,Cycling T/NK,4428,,119,2.687443541102078
184
+ 081_B_Single-cell_atlas_of_peripheral_immune_respon_Single-cell_atlas_of_peripheral_immune_response_to_SARS-CoV-2,Cycling activated T (CD38/HLA-DR),2816,,64,2.272727272727273
185
+ 081_B_Single-cell_atlas_of_peripheral_immune_respon_Single-cell_atlas_of_peripheral_immune_response_to_SARS-CoV-2,Proliferating T (label),2816,,189,6.7116477272727275
186
+ 081_B_Single-cell_atlas_of_peripheral_immune_respon_Single-cell_atlas_of_peripheral_immune_response_to_SARS-CoV-2,Plasmablast (label),8000,,188,2.35
187
+ 081_B_Single-cell_atlas_of_peripheral_immune_respon_Single-cell_atlas_of_peripheral_immune_response_to_SARS-CoV-2,Plasmablast (markers),8000,,223,2.7875
188
+ 081_B_Single-cell_atlas_of_peripheral_immune_respon_Single-cell_atlas_of_peripheral_immune_response_to_SARS-CoV-2,MS1 monocyte (IL1R2+),2313,,42,1.8158236057068742
189
+ 081_B_Single-cell_atlas_of_peripheral_immune_respon_Single-cell_atlas_of_peripheral_immune_response_to_SARS-CoV-2,Cycling monocyte (Ye 2026),2313,,143,6.182447038478167
190
+ 081_B_Single-cell_atlas_of_peripheral_immune_respon_Single-cell_atlas_of_peripheral_immune_response_to_SARS-CoV-2,ISG-high monocyte (positive control),2313,,937,40.51015996541288
191
+ 081_B_Single-cell_atlas_of_peripheral_immune_respon_Single-cell_atlas_of_peripheral_immune_response_to_SARS-CoV-2,ISG-high T,2816,,182,6.463068181818182
192
+ 081_B_Single-cell_atlas_of_peripheral_immune_respon_Single-cell_atlas_of_peripheral_immune_response_to_SARS-CoV-2,DN2 / ABC B,819,,24,2.93040293040293
193
+ 081_B_Single-cell_atlas_of_peripheral_immune_respon_Single-cell_atlas_of_peripheral_immune_response_to_SARS-CoV-2,HSPC,8000,,12,0.15
194
+ 081_B_Single-cell_atlas_of_peripheral_immune_respon_Single-cell_atlas_of_peripheral_immune_response_to_SARS-CoV-2,Cytotoxic CD4 T,933,,4,0.4287245444801715
195
+ 081_B_Single-cell_atlas_of_peripheral_immune_respon_Single-cell_atlas_of_peripheral_immune_response_to_SARS-CoV-2,Granulocyte-like (LDG),8000,,397,4.9625
196
+ 081_B_Single-cell_atlas_of_peripheral_immune_respon_Single-cell_atlas_of_peripheral_immune_response_to_SARS-CoV-2,Platelet signal in monocytes (negative control),2313,,75,3.2425421530479897
197
+ 093_C_Local_and_systemic_SARS-CoV-2_response_CELLxG_Local_and_systemic_SARS-CoV-2_response_CELLxGENE,C1Q-high monocyte (reference),1369,,32,2.337472607742878
198
+ 093_C_Local_and_systemic_SARS-CoV-2_response_CELLxG_Local_and_systemic_SARS-CoV-2_response_CELLxGENE,Cycling T/NK,5376,,10,0.18601190476190477
199
+ 093_C_Local_and_systemic_SARS-CoV-2_response_CELLxG_Local_and_systemic_SARS-CoV-2_response_CELLxGENE,Cycling activated T (CD38/HLA-DR),4398,,40,0.9095043201455207
200
+ 093_C_Local_and_systemic_SARS-CoV-2_response_CELLxG_Local_and_systemic_SARS-CoV-2_response_CELLxGENE,Proliferating T (label),4398,,16,0.36380172805820826
201
+ 093_C_Local_and_systemic_SARS-CoV-2_response_CELLxG_Local_and_systemic_SARS-CoV-2_response_CELLxGENE,Plasmablast (label),8000,,37,0.4625
202
+ 093_C_Local_and_systemic_SARS-CoV-2_response_CELLxG_Local_and_systemic_SARS-CoV-2_response_CELLxGENE,Plasmablast (markers),8000,,123,1.5375
203
+ 093_C_Local_and_systemic_SARS-CoV-2_response_CELLxG_Local_and_systemic_SARS-CoV-2_response_CELLxGENE,MS1 monocyte (IL1R2+),1369,,56,4.090577063550037
204
+ 093_C_Local_and_systemic_SARS-CoV-2_response_CELLxG_Local_and_systemic_SARS-CoV-2_response_CELLxGENE,Cycling monocyte (Ye 2026),1369,,12,0.8765522279035792
205
+ 093_C_Local_and_systemic_SARS-CoV-2_response_CELLxG_Local_and_systemic_SARS-CoV-2_response_CELLxGENE,ISG-high monocyte (positive control),1369,,352,25.712198685171657
206
+ 093_C_Local_and_systemic_SARS-CoV-2_response_CELLxG_Local_and_systemic_SARS-CoV-2_response_CELLxGENE,ISG-high T,4398,,351,7.980900409276944
207
+ 093_C_Local_and_systemic_SARS-CoV-2_response_CELLxG_Local_and_systemic_SARS-CoV-2_response_CELLxGENE,DN2 / ABC B,1020,,31,3.0392156862745097
208
+ 093_C_Local_and_systemic_SARS-CoV-2_response_CELLxG_Local_and_systemic_SARS-CoV-2_response_CELLxGENE,HSPC,8000,,19,0.2375
209
+ 093_C_Local_and_systemic_SARS-CoV-2_response_CELLxG_Local_and_systemic_SARS-CoV-2_response_CELLxGENE,Cytotoxic CD4 T,2022,,14,0.6923837784371909
210
+ 093_C_Local_and_systemic_SARS-CoV-2_response_CELLxG_Local_and_systemic_SARS-CoV-2_response_CELLxGENE,Granulocyte-like (LDG),8000,,85,1.0625
211
+ 093_C_Local_and_systemic_SARS-CoV-2_response_CELLxG_Local_and_systemic_SARS-CoV-2_response_CELLxGENE,Platelet signal in monocytes (negative control),1369,,99,7.231555880204529
212
+ 200_A_GSE275067_Immunobiology_of_Aging_Cohort_PBMC_Profiling,C1Q-high monocyte (reference),1007,,12,1.1916583912611718
213
+ 200_A_GSE275067_Immunobiology_of_Aging_Cohort_PBMC_Profiling,Cycling T/NK,5950,,8,0.13445378151260504
214
+ 200_A_GSE275067_Immunobiology_of_Aging_Cohort_PBMC_Profiling,Cycling activated T (CD38/HLA-DR),4943,,13,0.2629981792433745
215
+ 200_A_GSE275067_Immunobiology_of_Aging_Cohort_PBMC_Profiling,Proliferating T (label),4943,,110,2.2253692089823995
216
+ 200_A_GSE275067_Immunobiology_of_Aging_Cohort_PBMC_Profiling,Plasmablast (label),8000,,0,0.0
217
+ 200_A_GSE275067_Immunobiology_of_Aging_Cohort_PBMC_Profiling,Plasmablast (markers),8000,IGLL5,83,1.0375
218
+ 200_A_GSE275067_Immunobiology_of_Aging_Cohort_PBMC_Profiling,MS1 monocyte (IL1R2+),1007,,26,2.5819265143992056
219
+ 200_A_GSE275067_Immunobiology_of_Aging_Cohort_PBMC_Profiling,Cycling monocyte (Ye 2026),1007,,39,3.872889771598808
220
+ 200_A_GSE275067_Immunobiology_of_Aging_Cohort_PBMC_Profiling,ISG-high monocyte (positive control),1007,,373,37.040714995034755
221
+ 200_A_GSE275067_Immunobiology_of_Aging_Cohort_PBMC_Profiling,ISG-high T,4943,,134,2.7109043091240137
222
+ 200_A_GSE275067_Immunobiology_of_Aging_Cohort_PBMC_Profiling,DN2 / ABC B,0,,0,
223
+ 200_A_GSE275067_Immunobiology_of_Aging_Cohort_PBMC_Profiling,HSPC,8000,,12,0.15
224
+ 200_A_GSE275067_Immunobiology_of_Aging_Cohort_PBMC_Profiling,Cytotoxic CD4 T,2235,,24,1.0738255033557047
225
+ 200_A_GSE275067_Immunobiology_of_Aging_Cohort_PBMC_Profiling,Granulocyte-like (LDG),8000,,348,4.35
226
+ 200_A_GSE275067_Immunobiology_of_Aging_Cohort_PBMC_Profiling,Platelet signal in monocytes (negative control),1007,,236,23.435948361469713
227
+ 202_B_GSE161918_Time-resolved_Systems_Immunology_Reveals_a_Late_Juncture_Linked_to_Fatal_COVID-1,C1Q-high monocyte (reference),2783,,54,1.9403521379805966
228
+ 202_B_GSE161918_Time-resolved_Systems_Immunology_Reveals_a_Late_Juncture_Linked_to_Fatal_COVID-1,Cycling T/NK,4354,,44,1.0105649977032614
229
+ 202_B_GSE161918_Time-resolved_Systems_Immunology_Reveals_a_Late_Juncture_Linked_to_Fatal_COVID-1,Cycling activated T (CD38/HLA-DR),3547,,121,3.4113335212855933
230
+ 202_B_GSE161918_Time-resolved_Systems_Immunology_Reveals_a_Late_Juncture_Linked_to_Fatal_COVID-1,Proliferating T (label),3547,,15,0.422892585283338
231
+ 202_B_GSE161918_Time-resolved_Systems_Immunology_Reveals_a_Late_Juncture_Linked_to_Fatal_COVID-1,Plasmablast (label),8000,,19,0.2375
232
+ 202_B_GSE161918_Time-resolved_Systems_Immunology_Reveals_a_Late_Juncture_Linked_to_Fatal_COVID-1,Plasmablast (markers),8000,,103,1.2875
233
+ 202_B_GSE161918_Time-resolved_Systems_Immunology_Reveals_a_Late_Juncture_Linked_to_Fatal_COVID-1,MS1 monocyte (IL1R2+),2783,,742,26.66187567373338
234
+ 202_B_GSE161918_Time-resolved_Systems_Immunology_Reveals_a_Late_Juncture_Linked_to_Fatal_COVID-1,Cycling monocyte (Ye 2026),2783,,72,2.5871361839741285
235
+ 202_B_GSE161918_Time-resolved_Systems_Immunology_Reveals_a_Late_Juncture_Linked_to_Fatal_COVID-1,ISG-high monocyte (positive control),2783,,456,16.38519583183615
236
+ 202_B_GSE161918_Time-resolved_Systems_Immunology_Reveals_a_Late_Juncture_Linked_to_Fatal_COVID-1,ISG-high T,3547,,171,4.820975472230054
237
+ 202_B_GSE161918_Time-resolved_Systems_Immunology_Reveals_a_Late_Juncture_Linked_to_Fatal_COVID-1,DN2 / ABC B,600,,11,1.8333333333333333
238
+ 202_B_GSE161918_Time-resolved_Systems_Immunology_Reveals_a_Late_Juncture_Linked_to_Fatal_COVID-1,HSPC,8000,,6,0.075
239
+ 202_B_GSE161918_Time-resolved_Systems_Immunology_Reveals_a_Late_Juncture_Linked_to_Fatal_COVID-1,Cytotoxic CD4 T,1805,,47,2.6038781163434903
240
+ 202_B_GSE161918_Time-resolved_Systems_Immunology_Reveals_a_Late_Juncture_Linked_to_Fatal_COVID-1,Granulocyte-like (LDG),8000,,185,2.3125
241
+ 202_B_GSE161918_Time-resolved_Systems_Immunology_Reveals_a_Late_Juncture_Linked_to_Fatal_COVID-1,Platelet signal in monocytes (negative control),2783,,62,2.227811713977722
242
+ 203_B_CELLxGENE_665714af_Ancestral_and_environmental_diversity_shape_the_immune_landscape_in_Indonesia,C1Q-high monocyte (reference),1089,,17,1.5610651974288339
243
+ 203_B_CELLxGENE_665714af_Ancestral_and_environmental_diversity_shape_the_immune_landscape_in_Indonesia,Cycling T/NK,5793,,12,0.20714655618850336
244
+ 203_B_CELLxGENE_665714af_Ancestral_and_environmental_diversity_shape_the_immune_landscape_in_Indonesia,Cycling activated T (CD38/HLA-DR),5010,,70,1.3972055888223553
245
+ 203_B_CELLxGENE_665714af_Ancestral_and_environmental_diversity_shape_the_immune_landscape_in_Indonesia,Proliferating T (label),5010,,9,0.17964071856287425
246
+ 203_B_CELLxGENE_665714af_Ancestral_and_environmental_diversity_shape_the_immune_landscape_in_Indonesia,Plasmablast (label),8000,,49,0.6125
247
+ 203_B_CELLxGENE_665714af_Ancestral_and_environmental_diversity_shape_the_immune_landscape_in_Indonesia,Plasmablast (markers),8000,,178,2.225
248
+ 203_B_CELLxGENE_665714af_Ancestral_and_environmental_diversity_shape_the_immune_landscape_in_Indonesia,MS1 monocyte (IL1R2+),1089,,19,1.7447199265381084
249
+ 203_B_CELLxGENE_665714af_Ancestral_and_environmental_diversity_shape_the_immune_landscape_in_Indonesia,Cycling monocyte (Ye 2026),1089,,12,1.1019283746556474
250
+ 203_B_CELLxGENE_665714af_Ancestral_and_environmental_diversity_shape_the_immune_landscape_in_Indonesia,ISG-high monocyte (positive control),1089,,133,12.213039485766759
251
+ 203_B_CELLxGENE_665714af_Ancestral_and_environmental_diversity_shape_the_immune_landscape_in_Indonesia,ISG-high T,5010,,59,1.1776447105788423
252
+ 203_B_CELLxGENE_665714af_Ancestral_and_environmental_diversity_shape_the_immune_landscape_in_Indonesia,DN2 / ABC B,919,,90,9.793253536452665
253
+ 203_B_CELLxGENE_665714af_Ancestral_and_environmental_diversity_shape_the_immune_landscape_in_Indonesia,HSPC,8000,,0,0.0
254
+ 203_B_CELLxGENE_665714af_Ancestral_and_environmental_diversity_shape_the_immune_landscape_in_Indonesia,Cytotoxic CD4 T,1841,,14,0.7604562737642585
255
+ 203_B_CELLxGENE_665714af_Ancestral_and_environmental_diversity_shape_the_immune_landscape_in_Indonesia,Granulocyte-like (LDG),8000,,72,0.9
256
+ 203_B_CELLxGENE_665714af_Ancestral_and_environmental_diversity_shape_the_immune_landscape_in_Indonesia,Platelet signal in monocytes (negative control),1089,,62,5.693296602387512
257
+ 204_B_CELLxGENE_cHSPC_aging_MDS_Human_circulating_hematopoietic_stem_and_progenitor_cells_in_aging_cytopenia_and,C1Q-high monocyte (reference),342,,2,0.5847953216374269
258
+ 204_B_CELLxGENE_cHSPC_aging_MDS_Human_circulating_hematopoietic_stem_and_progenitor_cells_in_aging_cytopenia_and,Cycling T/NK,810,,5,0.6172839506172839
259
+ 204_B_CELLxGENE_cHSPC_aging_MDS_Human_circulating_hematopoietic_stem_and_progenitor_cells_in_aging_cytopenia_and,Cycling activated T (CD38/HLA-DR),807,,47,5.8240396530359355
260
+ 204_B_CELLxGENE_cHSPC_aging_MDS_Human_circulating_hematopoietic_stem_and_progenitor_cells_in_aging_cytopenia_and,Proliferating T (label),807,,5,0.6195786864931846
261
+ 204_B_CELLxGENE_cHSPC_aging_MDS_Human_circulating_hematopoietic_stem_and_progenitor_cells_in_aging_cytopenia_and,Plasmablast (label),8750,,4,0.045714285714285714
262
+ 204_B_CELLxGENE_cHSPC_aging_MDS_Human_circulating_hematopoietic_stem_and_progenitor_cells_in_aging_cytopenia_and,Plasmablast (markers),8750,,29,0.3314285714285714
263
+ 204_B_CELLxGENE_cHSPC_aging_MDS_Human_circulating_hematopoietic_stem_and_progenitor_cells_in_aging_cytopenia_and,MS1 monocyte (IL1R2+),342,,0,0.0
264
+ 204_B_CELLxGENE_cHSPC_aging_MDS_Human_circulating_hematopoietic_stem_and_progenitor_cells_in_aging_cytopenia_and,Cycling monocyte (Ye 2026),342,,5,1.4619883040935673
265
+ 204_B_CELLxGENE_cHSPC_aging_MDS_Human_circulating_hematopoietic_stem_and_progenitor_cells_in_aging_cytopenia_and,ISG-high monocyte (positive control),342,,51,14.912280701754385
266
+ 204_B_CELLxGENE_cHSPC_aging_MDS_Human_circulating_hematopoietic_stem_and_progenitor_cells_in_aging_cytopenia_and,ISG-high T,807,,6,0.7434944237918215
267
+ 204_B_CELLxGENE_cHSPC_aging_MDS_Human_circulating_hematopoietic_stem_and_progenitor_cells_in_aging_cytopenia_and,DN2 / ABC B,1856,,76,4.094827586206897
268
+ 204_B_CELLxGENE_cHSPC_aging_MDS_Human_circulating_hematopoietic_stem_and_progenitor_cells_in_aging_cytopenia_and,HSPC,8750,,4258,48.66285714285714
269
+ 204_B_CELLxGENE_cHSPC_aging_MDS_Human_circulating_hematopoietic_stem_and_progenitor_cells_in_aging_cytopenia_and,Cytotoxic CD4 T,784,,0,0.0
270
+ 204_B_CELLxGENE_cHSPC_aging_MDS_Human_circulating_hematopoietic_stem_and_progenitor_cells_in_aging_cytopenia_and,Granulocyte-like (LDG),8750,,186,2.125714285714286
271
+ 204_B_CELLxGENE_cHSPC_aging_MDS_Human_circulating_hematopoietic_stem_and_progenitor_cells_in_aging_cytopenia_and,Platelet signal in monocytes (negative control),342,,50,14.619883040935672
272
+ 300b_A_GSE132802_DRESS_DiHS_PBMC_only_scRNAseq,C1Q-high monocyte (reference),1084,,162,14.944649446494465
273
+ 300b_A_GSE132802_DRESS_DiHS_PBMC_only_scRNAseq,Cycling T/NK,6134,,401,6.537332898597978
274
+ 300b_A_GSE132802_DRESS_DiHS_PBMC_only_scRNAseq,Cycling activated T (CD38/HLA-DR),5745,,544,9.469103568320278
275
+ 300b_A_GSE132802_DRESS_DiHS_PBMC_only_scRNAseq,Proliferating T (label),5745,,1226,21.34029590948651
276
+ 300b_A_GSE132802_DRESS_DiHS_PBMC_only_scRNAseq,Plasmablast (label),8000,,69,0.8625
277
+ 300b_A_GSE132802_DRESS_DiHS_PBMC_only_scRNAseq,Plasmablast (markers),8000,,164,2.05
278
+ 300b_A_GSE132802_DRESS_DiHS_PBMC_only_scRNAseq,MS1 monocyte (IL1R2+),1084,,27,2.4907749077490773
279
+ 300b_A_GSE132802_DRESS_DiHS_PBMC_only_scRNAseq,Cycling monocyte (Ye 2026),1084,,67,6.180811808118081
280
+ 300b_A_GSE132802_DRESS_DiHS_PBMC_only_scRNAseq,ISG-high monocyte (positive control),1084,,123,11.346863468634686
281
+ 300b_A_GSE132802_DRESS_DiHS_PBMC_only_scRNAseq,ISG-high T,5745,,158,2.7502175805047866
282
+ 300b_A_GSE132802_DRESS_DiHS_PBMC_only_scRNAseq,DN2 / ABC B,554,,31,5.595667870036101
283
+ 300b_A_GSE132802_DRESS_DiHS_PBMC_only_scRNAseq,HSPC,8000,,10,0.125
284
+ 300b_A_GSE132802_DRESS_DiHS_PBMC_only_scRNAseq,Cytotoxic CD4 T,2775,,8,0.2882882882882883
285
+ 300b_A_GSE132802_DRESS_DiHS_PBMC_only_scRNAseq,Granulocyte-like (LDG),8000,,249,3.1125
286
+ 300b_A_GSE132802_DRESS_DiHS_PBMC_only_scRNAseq,Platelet signal in monocytes (negative control),1084,,29,2.6752767527675276
287
+ 301_A_GSE163121_SLE_healthy_Bcell_PBMC_scRNAseq,C1Q-high monocyte (reference),262,C1QC,0,0.0
288
+ 301_A_GSE163121_SLE_healthy_Bcell_PBMC_scRNAseq,Cycling T/NK,694,,8,1.1527377521613833
289
+ 301_A_GSE163121_SLE_healthy_Bcell_PBMC_scRNAseq,Cycling activated T (CD38/HLA-DR),539,,3,0.5565862708719852
290
+ 301_A_GSE163121_SLE_healthy_Bcell_PBMC_scRNAseq,Proliferating T (label),539,,1,0.18552875695732837
291
+ 301_A_GSE163121_SLE_healthy_Bcell_PBMC_scRNAseq,Plasmablast (label),8000,,111,1.3875
292
+ 301_A_GSE163121_SLE_healthy_Bcell_PBMC_scRNAseq,Plasmablast (markers),8000,,238,2.975
293
+ 301_A_GSE163121_SLE_healthy_Bcell_PBMC_scRNAseq,MS1 monocyte (IL1R2+),262,,4,1.5267175572519085
294
+ 301_A_GSE163121_SLE_healthy_Bcell_PBMC_scRNAseq,Cycling monocyte (Ye 2026),262,,1,0.3816793893129771
295
+ 301_A_GSE163121_SLE_healthy_Bcell_PBMC_scRNAseq,ISG-high monocyte (positive control),262,,29,11.068702290076336
296
+ 301_A_GSE163121_SLE_healthy_Bcell_PBMC_scRNAseq,ISG-high T,539,,7,1.2987012987012987
297
+ 301_A_GSE163121_SLE_healthy_Bcell_PBMC_scRNAseq,DN2 / ABC B,6960,,624,8.96551724137931
298
+ 301_A_GSE163121_SLE_healthy_Bcell_PBMC_scRNAseq,HSPC,8000,,16,0.2
299
+ 301_A_GSE163121_SLE_healthy_Bcell_PBMC_scRNAseq,Cytotoxic CD4 T,294,,0,0.0
300
+ 301_A_GSE163121_SLE_healthy_Bcell_PBMC_scRNAseq,Granulocyte-like (LDG),8000,,25,0.3125
301
+ 301_A_GSE163121_SLE_healthy_Bcell_PBMC_scRNAseq,Platelet signal in monocytes (negative control),262,,24,9.16030534351145
302
+ 302_A_GSE314010_SLE_IL36_stim_PBMC_scRNAseq,C1Q-high monocyte (reference),1335,,76,5.692883895131086
303
+ 302_A_GSE314010_SLE_IL36_stim_PBMC_scRNAseq,Cycling T/NK,5745,,5,0.08703220191470844
304
+ 302_A_GSE314010_SLE_IL36_stim_PBMC_scRNAseq,Cycling activated T (CD38/HLA-DR),5193,,62,1.1939148854226844
305
+ 302_A_GSE314010_SLE_IL36_stim_PBMC_scRNAseq,Proliferating T (label),5193,,3,0.057770075101097634
306
+ 302_A_GSE314010_SLE_IL36_stim_PBMC_scRNAseq,Plasmablast (label),8000,,9,0.1125
307
+ 302_A_GSE314010_SLE_IL36_stim_PBMC_scRNAseq,Plasmablast (markers),8000,,76,0.95
308
+ 302_A_GSE314010_SLE_IL36_stim_PBMC_scRNAseq,MS1 monocyte (IL1R2+),1335,,76,5.692883895131086
309
+ 302_A_GSE314010_SLE_IL36_stim_PBMC_scRNAseq,Cycling monocyte (Ye 2026),1335,,58,4.344569288389513
310
+ 302_A_GSE314010_SLE_IL36_stim_PBMC_scRNAseq,ISG-high monocyte (positive control),1335,,353,26.44194756554307
311
+ 302_A_GSE314010_SLE_IL36_stim_PBMC_scRNAseq,ISG-high T,5193,,123,2.368573079145003
312
+ 302_A_GSE314010_SLE_IL36_stim_PBMC_scRNAseq,DN2 / ABC B,747,,32,4.28380187416332
313
+ 302_A_GSE314010_SLE_IL36_stim_PBMC_scRNAseq,HSPC,8000,,6,0.075
314
+ 302_A_GSE314010_SLE_IL36_stim_PBMC_scRNAseq,Cytotoxic CD4 T,2254,,17,0.7542147293700089
315
+ 302_A_GSE314010_SLE_IL36_stim_PBMC_scRNAseq,Granulocyte-like (LDG),8000,,571,7.1375
316
+ 302_A_GSE314010_SLE_IL36_stim_PBMC_scRNAseq,Platelet signal in monocytes (negative control),1335,,11,0.8239700374531835
317
+ 304_A_Parse_10M_PBMC_12donor_90cytokines,C1Q-high monocyte (reference),1371,,64,4.6681254558716265
318
+ 304_A_Parse_10M_PBMC_12donor_90cytokines,Cycling T/NK,5580,,8,0.14336917562724014
319
+ 304_A_Parse_10M_PBMC_12donor_90cytokines,Cycling activated T (CD38/HLA-DR),5107,,23,0.45036224789504603
320
+ 304_A_Parse_10M_PBMC_12donor_90cytokines,Proliferating T (label),5107,,65,1.2727628744859996
321
+ 304_A_Parse_10M_PBMC_12donor_90cytokines,Plasmablast (label),8000,,47,0.5875
322
+ 304_A_Parse_10M_PBMC_12donor_90cytokines,Plasmablast (markers),8000,,50,0.625
323
+ 304_A_Parse_10M_PBMC_12donor_90cytokines,MS1 monocyte (IL1R2+),1371,,43,3.136396790663749
324
+ 304_A_Parse_10M_PBMC_12donor_90cytokines,Cycling monocyte (Ye 2026),1371,,20,1.4587892049598834
325
+ 304_A_Parse_10M_PBMC_12donor_90cytokines,ISG-high monocyte (positive control),1371,,1013,73.88767323121809
326
+ 304_A_Parse_10M_PBMC_12donor_90cytokines,ISG-high T,5107,,1906,37.321323673389465
327
+ 304_A_Parse_10M_PBMC_12donor_90cytokines,DN2 / ABC B,858,,46,5.361305361305361
328
+ 304_A_Parse_10M_PBMC_12donor_90cytokines,HSPC,8000,,3,0.0375
329
+ 304_A_Parse_10M_PBMC_12donor_90cytokines,Cytotoxic CD4 T,2711,,2,0.07377351530800443
330
+ 304_A_Parse_10M_PBMC_12donor_90cytokines,Granulocyte-like (LDG),8000,CTSG CAMP LCN2,349,4.3625
331
+ 304_A_Parse_10M_PBMC_12donor_90cytokines,Platelet signal in monocytes (negative control),1371,GP9,12,0.87527352297593
paper-releases/pbisc-diffusion/updates/20261004T165054Z-rare-states-screen/diffusion/dataset/server_1/model8/plans/rare_states_screen_20261004/out/per_sample.csv ADDED
The diff for this file is too large to render. See raw diff